Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs
- 23 March 2000
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 59 (10) , 1245-1252
- https://doi.org/10.1016/s0006-2952(00)00270-7
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteinsProceedings of the National Academy of Sciences, 1997
- MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates PhosphatidylcholineCell, 1996
- Role of Multidrug Resistance P-glycoproteins in Cholesterol BiosynthesisJournal of Biological Chemistry, 1996
- Reconstitution of Drug Transport by Purified P-glycoproteinPublished by Elsevier ,1995
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammalsPharmacology & Therapeutics, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCEAnnual Review of Biochemistry, 1989